Hogan Lovells US LLP

Medical Device and Technology Regulatory

Counsel

With a background in biology and economics, Kristin Zielinski Duggan provides strategic advice to companies on scientific and U.S. Food and Drug Administration (FDA) regulatory challenges, while always keeping business needs in mind. For over 20 years, she has been counseling cutting-edge companies regarding the development and regulation of medical devices and combination products. Kristin has a wealth of experience with the entire FDA regulatory process from concept through commercialization, and specializes in FDA Advisory Panels.

Kristin previously served as Vice President for Strategic Consulting at a Washington, D.C.-based scientific consulting firm. Throughout her career, she has published and presented on various FDA regulatory issues. She is also an adjunct professor at Georgetown University's School of Nursing and Health Studies.

English

Member, Regulatory Affairs Professionals Society (RAPS)Member, Food and Drug Law Institute (FDLI)

J.D., Georgetown University Law Center, 2015; B.A., University of Virginia, 1998

Running, boating